These findings suggest that CYGB plays an important role in protecting hCPCs against cell death induced by oxidative stress, providing a potential therapeutic target for enhancing the effectiveness of cardiac stem/progenitor cell therapy for ischemic heart disease. The gene discussed is CYGB; the disease is coronary artery disorder.